Torrent Pharmaceuticals Management
Management Kriterienprüfungen 3/4
Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.
Wichtige Informationen
Samir Mehta
Geschäftsführender
₹230.0m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 0.02% |
| Amtszeit als Geschäftsführer | 35.5yrs |
| Eigentum des Geschäftsführers | 0.0002% |
| Durchschnittliche Amtszeit des Managements | 2.5yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 3.3yrs |
Jüngste Management Updates
Recent updates
Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is On The Mark
Apr 16
Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?
Mar 03Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00
Feb 05Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings
Jan 07Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Rather Sparingly
Nov 14Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jun 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Mar 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jul 25Torrent Pharmaceuticals' (NSE:TORNTPHARM) Soft Earnings Don't Show The Whole Picture
Jun 02Estimating The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
May 25A Look At The Intrinsic Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
Feb 18Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹25.00
Jan 27Here's Why Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt Responsibly
Jan 04Here's Why I Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is An Interesting Stock
Dec 14A Look At The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
Nov 07Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Sep 30Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Deserve A Spot On Your Watchlist?
Sep 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jul 02I Ran A Stock Scan For Earnings Growth And Torrent Pharmaceuticals (NSE:TORNTPHARM) Passed With Ease
Jun 01Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Shares Could Be 30% Above Their Intrinsic Value Estimate
May 14Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?
Mar 23The Torrent Pharmaceuticals (NSE:TORNTPHARM) Share Price Has Gained 84% And Shareholders Are Hoping For More
Mar 02Is It Smart To Buy Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Before It Goes Ex-Dividend?
Feb 10Do Torrent Pharmaceuticals's (NSE:TORNTPHARM) Earnings Warrant Your Attention?
Jan 19Should You Be Impressed By Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) ROE?
Dec 29Is Torrent Pharmaceuticals (NSE:TORNTPHARM) Using Too Much Debt?
Dec 08
Investors Who Bought Torrent Pharmaceuticals (NSE:TORNTPHARM) Shares Three Years Ago Are Now Up 118%
Nov 16Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | ₹17b |
| Dec 31 2023 | n/a | n/a | ₹15b |
| Sep 30 2023 | n/a | n/a | ₹13b |
| Jun 30 2023 | n/a | n/a | ₹13b |
| Mar 31 2023 | ₹230m | ₹40k | ₹12b |
| Dec 31 2022 | n/a | n/a | ₹8b |
| Sep 30 2022 | n/a | n/a | ₹8b |
| Jun 30 2022 | n/a | n/a | ₹8b |
| Mar 31 2022 | ₹200m | ₹40k | ₹8b |
| Dec 31 2021 | n/a | n/a | ₹12b |
| Sep 30 2021 | n/a | n/a | ₹13b |
| Jun 30 2021 | n/a | n/a | ₹13b |
| Mar 31 2021 | ₹200m | ₹40k | ₹13b |
| Dec 31 2020 | n/a | n/a | ₹12b |
| Sep 30 2020 | n/a | n/a | ₹12b |
| Jun 30 2020 | n/a | n/a | ₹11b |
| Mar 31 2020 | ₹200m | ₹40k | ₹10b |
| Dec 31 2019 | n/a | n/a | ₹6b |
| Sep 30 2019 | n/a | n/a | ₹6b |
| Jun 30 2019 | n/a | n/a | ₹5b |
| Mar 31 2019 | ₹150m | ₹40k | ₹4b |
| Dec 31 2018 | n/a | n/a | ₹8b |
| Sep 30 2018 | n/a | n/a | ₹6b |
| Jun 30 2018 | n/a | n/a | ₹7b |
| Mar 31 2018 | ₹150m | ₹40k | ₹7b |
Vergütung im Vergleich zum Markt: SamirDie Gesamtvergütung ($USD2.77M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Indian ($USD1.03M).
Entschädigung vs. Einkommen: SamirDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.
Geschäftsführer
Samir Mehta (60 yo)
35.5yrs
Amtszeit
₹230,040,000
Vergütung
Mr. Samir Uttamlal Mehta, B.Com., MBA serves as a Managing Director of Torrent Pharmaceuticals Limited since 1989. Mr. Mehta served as Managing Director of Torrent Power Limited. Mr. Mehta has been associa...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Executive Chairman & MD | no data | ₹230.04m | 0.00024% ₹ 2.3m | |
| Executive Director of Operations & Whole-Time Director | no data | ₹58.87m | keine Daten | |
| Whole-Time Director | 1.9yrs | ₹20.59m | 0.000060% ₹ 572.8k | |
| Executive Director of Finance & CFO | 5.8yrs | ₹16.30m | keine Daten | |
| Company Secretary & Compliance Officer | 1.9yrs | keine Daten | keine Daten | |
| Chief Customer Service Officer | 3.1yrs | keine Daten | keine Daten | |
| Vice President of Human Resource | no data | ₹6.56m | keine Daten | |
| Vice President of Works | no data | ₹8.25m | keine Daten | |
| Vice President of Works | no data | ₹7.28m | keine Daten | |
| Vice President of Finance | no data | ₹6.35m | keine Daten | |
| Executive Director of International Business | no data | keine Daten | keine Daten |
2.5yrs
Durchschnittliche Betriebszugehörigkeit
56yo
Durchschnittliches Alter
Erfahrenes Management: TORNTPHARMDas Führungsteam des Unternehmens gilt als erfahren (2.3 Jahre durchschnittliche Betriebszugehörigkeit).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Executive Chairman & MD | 35.5yrs | ₹230.04m | 0.00024% ₹ 2.3m | |
| Executive Director of Operations & Whole-Time Director | 4.3yrs | ₹58.87m | keine Daten | |
| Whole-Time Director | 1.9yrs | ₹20.59m | 0.000060% ₹ 572.8k | |
| Chairman Emeritus | 10yrs | keine Daten | 0.00030% ₹ 2.9m | |
| Independent Director | less than a year | keine Daten | keine Daten | |
| Independent Director | 2yrs | ₹4.20m | keine Daten | |
| Independent Director | 5.9yrs | ₹6.90m | 0.00052% ₹ 5.0m | |
| Independent Director | 5.3yrs | ₹7.90m | keine Daten | |
| Director | less than a year | keine Daten | keine Daten | |
| Independent Director | 2.2yrs | ₹7.10m | keine Daten |
3.3yrs
Durchschnittliche Betriebszugehörigkeit
58yo
Durchschnittliches Alter
Erfahrener Vorstand: TORNTPHARMDie Vorstandsmitglieder gelten als erfahren (4.2 Jahre durchschnittliche Amtszeit).